The value of a radioimmunological monitoring in cancer patients treated with interferon alpha.

MLA

Bernier, J., et al. “The Value of a Radioimmunological Monitoring in Cancer Patients Treated with Interferon Alpha.” Bulletin Du Cancer, vol. 71, no. 5, 1984, pp. 405–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6525465&authtype=sso&custid=ns315887.

APA

Bernier, J., Reuter, A., Vrindts-Gevaert, Y., Franchimont, P., Pouillart, P., Bretaudeau, B., Falcoff, E., & Magdelenat, H. (1984). The value of a radioimmunological monitoring in cancer patients treated with interferon alpha. Bulletin Du Cancer, 71(5), 405–411.

Chicago

Bernier, J, A Reuter, Y Vrindts-Gevaert, P Franchimont, P Pouillart, B Bretaudeau, E Falcoff, and H Magdelenat. 1984. “The Value of a Radioimmunological Monitoring in Cancer Patients Treated with Interferon Alpha.” Bulletin Du Cancer 71 (5): 405–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6525465&authtype=sso&custid=ns315887.